XML 76 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule Of Loss Before Income Tax

Loss before income taxes was as follows for the years ended December 31, (in thousands):

 

 

 

2022

 

 

2021

 

U.S. operations

 

$

(73,132

)

 

$

(61,541

)

Non-U.S. operations

 

 

(2,927

)

 

 

(6,746

)

Loss before provision for income taxes

 

$

(76,059

)

 

$

(68,287

)

Schedule of Components of Income Tax Expense (Benefit)

The components of the provision for income taxes was as follows for the years ended December 31, (in thousands):

 

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

U.S.

 

$

 

 

$

 

State and local

 

 

1

 

 

 

1

 

Foreign

 

 

1,936

 

 

 

 

Total current

 

 

1,937

 

 

 

1

 

Deferred:

 

 

 

 

 

 

U.S.

 

 

 

 

 

 

Total deferred

 

 

 

 

 

 

Total provision for income taxes

 

$

1,937

 

 

$

1

 

Schedule of Effective Income Tax Rate Reconciliation reconciliation of the Company’s statutory income tax rate to the Company’s effective income tax rate for the years ended December 31, was as follows:

 

 

 

2022

 

 

2021

 

Income tax benefit at Cayman statutory rate

 

 

0.00

%

 

 

0.00

%

U.S. and non-U.S. rate differential

 

 

21.57

%

 

 

19.49

%

State taxes

 

 

4.77

%

 

 

3.94

%

R&D credits

 

 

0.73

%

 

 

3.00

%

Change in valuation allowance

 

 

(27.61

%)

 

 

(25.79

%)

Share-based compensation

 

 

(3.62

%)

 

 

(0.66

%)

Ambrx Shanghai reorganization

 

 

1.77

%

 

 

0.00

%

Other, net

 

 

(0.16

%)

 

 

0.02

%

Effective tax rate

 

 

(2.55

%)

 

 

(0.00

%)

Schedule of Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred tax assets as of December 31, are shown below (in thousands):

 

 

 

2022

 

 

2021

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

57,647

 

 

$

48,179

 

R&D credits

 

 

16,385

 

 

 

14,317

 

Capitalized R&D

 

 

8,980

 

 

 

 

Lease liabilities

 

 

3,110

 

 

 

3,662

 

Share-based compensation

 

 

1,219

 

 

 

3,223

 

Deferred revenues

 

 

454

 

 

 

1,575

 

Intangible assets

 

 

337

 

 

 

 

Other

 

 

945

 

 

 

1,047

 

Total deferred tax assets

 

 

89,077

 

 

 

72,003

 

Deferred tax liabilities:

 

 

 

 

 

 

IPR&D

 

 

(5,436

)

 

 

(5,841

)

Right-of-use assets

 

 

(2,847

)

 

 

(3,553

)

Intangible assets

 

 

 

 

 

(2,445

)

Total deferred tax liabilities

 

 

(8,283

)

 

 

(11,839

)

Net deferred tax assets

 

 

80,794

 

 

 

60,164

 

Less: valuation allowance

 

 

(81,674

)

 

 

(61,044

)

 

 

$

(880

)

 

$

(880

)

Schedule of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows (in thousands):

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

Beginning balance

 

$

2,767

 

 

$

2,282

 

Additions based on tax positions related to the current year

 

 

1,958

 

 

 

485

 

Ending balance

 

$

4,725

 

 

$

2,767